The Ang2 levels were also elevated in COVID-19 patients with heart disease, who either died from COVID-19-related complications (ANOVA P = 0.0001) or had adverse clinical outcomes (either death or prolonged hospitalization (>30 days); ANOVA P = 0.001). Here, ANGPT2 is linked to heart disorder.